Navigation path

Additional tools

  • Print version
  • Decrease text
  • Increase text
  • Choose high contrast version
  • Choose standard colour version

Profile of registrant


Identification number in the register: 60329985751-43
Registration date: 28/04/11 18:17:56

The information on this organisation was last modified on 07/04/14 10:59:12
The date of the last annual update was 07/04/14 10:59:12

Registrant : Organisation or self-employed individual

Name/company name: Shire
Acronym: Shire
Legal status: Limited company
Website address:


Section: II - In-house lobbyists and trade/professional associations
and more precisely: Companies & groups

Person with legal responsibility

Surname, Name: Mr  Flemming Ornskov
Position: Chief Executive Officer

Permanent person in charge of EU relations

Surname, Name: Mr  Emmanuel Chantelot
Position: Senior Director, European Government Relations and Public Affairs

Contact details:

Contact details of organisation's head office: 5 Riverwalk; Citywest Business Campus 
Dublin 24
Telephone number: (+353) 1 429 7700
Fax number: (+) 
Other contact information: Brussels Office
Shire Belgium
Lambroekstraat 5c
1831 Diegem
Tel +32 (0)27110230
Fax +32 0)27110231

Goals / remit

Goals / remit of the organisation: Shire is an international specialty biopharmaceutical company focused on a single purpose: to enable people with life-altering conditions to lead better lives.

Shire focuses its business on rare diseases, neuroscience, gastrointestinal conditions, regenerative medicine and internal medicine.
The organisation's fields of interests are:
  • European
  • global

Number of persons engaged in activities falling under the scope of the Transparency Register

Number of persons: 3
Complementary information:

Persons accredited for access to European Parliament premises

First name Surname Start Date End Date
Emmanuel Chantelot 15/05/14 13/05/15
Nicholas Edwards 16/05/14 14/05/15
Maciej Gajewski 13/05/14 08/05/15


Main EU initiatives covered the year before by activities falling under the scope of the Transparency Register:

Shire engages in debates on issues relevant to the biopharmaceutical sector. Shire supports equal access to innovative medicines in Europe and research and innovation in the healthcare sector.

Shire also interacts with the EU Institutions in relation to legislation which has impact on the industry, for example Shire participates in relevant public consultations.

Fields of interest for e-mail alerts on consultations and roadmaps;

Fields declared by the organisation:
  • Consumer Affairs
  • Education
  • Employment and Social Affairs
  • Enterprise
  • General and Institutional Affairs
  • Internal Market
  • Public Health
  • Research and Technology
  • Trade
  • Youth


Information on (i) organisation's membership of any associations/federations/confederations or (ii) relationships to other bodies in formal or informal networks.

Shire is a member of the European Association of Bioindustries (EuropaBio), European Federation of Pharmaceutical Industries and Associations (EFPIA), European Biopharmaceutical Enterprises (EBE) and the American Chamber of Commerce to the European Union (AmCham EU).

Financial data

Financial year: 01/2013 - 12/2013
Estimated costs to the organisation directly related to representing interests to EU institutions in that year: 200000  € - 250000  €
Amount and source of funding received from the EU institutions in financial year n-1 of registration
Procurement: 0 €
Grants: 0 €
Other (financial) information provided by the organisation:

Code of conduct

By its registration the organisation has signed the Transparency Register Code of Conduct.